Safety, tolerability, and immunogenicity of V114 pneumococcal vaccine compared with PCV13 in a 2+1 regimen in healthy infants: A phase III study (PNEU-PED-EU-2)

Thomas Benfield, Mika Rämet, Piero Valentini, Ilkka Seppä, Ron Dagan, Peter Richmond, Swati Mercer, Clay Churchill, Robert Lupinacci, Richard McFetridge, Jun Park, Frederick Wittke, Natalie Banniettis, Luwy Musey, Kara Bickham, Janusz Kaminski

    Research output: Contribution to journalArticleScientificpeer-review

    5 Citations (Scopus)
    10 Downloads (Pure)

    Fingerprint

    Dive into the research topics of 'Safety, tolerability, and immunogenicity of V114 pneumococcal vaccine compared with PCV13 in a 2+1 regimen in healthy infants: A phase III study (PNEU-PED-EU-2)'. Together they form a unique fingerprint.

    Keyphrases

    Immunology and Microbiology